These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 13448)

  • 1. Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment.
    Ebstein RP; Biederman J; Rimon R; Zohar J; Belmaker RH
    Psychopharmacology (Berl); 1976 Dec; 51(1):71-4. PubMed ID: 13448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low CSF concentrations of cyclic GMP in schizophrenia.
    Gattaz WF; Cramer H; Beckmann H
    Br J Psychiatry; 1983 Mar; 142():288-91. PubMed ID: 6134562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patients.
    Gattaz WF; Cramer H; Beckmann H
    Biol Psychiatry; 1984 Aug; 19(8):1229-35. PubMed ID: 6149769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of L-dopa and propranolol on human CSF cyclic nucleotides.
    Belmaker RH; Ebstein RP; Biederman J; Stern R; Berman M; van Praag HM
    Psychopharmacology (Berl); 1978 Jul; 58(3):307-10. PubMed ID: 210480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic nucleotides in mental disorder.
    Belmaker RH; Zohar J; Ebstein RP
    Adv Cyclic Nucleotide Res; 1980; 12():187-98. PubMed ID: 6250353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium and calcium in the CSF of schizophrenic patients and healthy controls: correlations with cyclic GMP.
    Gattaz WF; Kattermann R; Gattaz D; Beckmann H
    Biol Psychiatry; 1983 Aug; 18(8):935-9. PubMed ID: 6137251
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.
    Glovinsky D; Kalogeras KT; Kirch DG; Suddath R; Wyatt RJ
    Schizophr Res; 1994 Feb; 11(3):273-6. PubMed ID: 7910756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
    Nagao T; Ohshimo T; Mitsunobu K; Sato M; Otsuki S
    Biol Psychiatry; 1979 Jun; 14(3):509-23. PubMed ID: 38867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP in the CSF of patients with schizophrenia.
    Biederman J; Rimon R; Ebstein R; Belmaker RH; Davidson JT
    Br J Psychiatry; 1977 Jan; 130():64-7. PubMed ID: 188506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does neuroleptic blocking of dopamine receptors continue after chronic treatment?
    Belmaker RH; Dasberg H; Ebstein RP
    Prog Biochem Pharmacol; 1980; 16():109-18. PubMed ID: 6108567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on a time-dependent model of neuroleptic action.
    Pickar D
    Schizophr Bull; 1988; 14(2):255-68. PubMed ID: 2904694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher cerebrospinal fluid angiotensin-converting enzyme levels in neuroleptic-treated than in drug-free patients with schizophrenia.
    Wahlbeck K; Ahokas A; Miettinen K; Nikkilä H; Rimón R
    Schizophr Bull; 1998; 24(3):391-7. PubMed ID: 9718631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of CSF dopamine, its metabolites and noradrenalin after withdrawal of chronic neuroleptic treatment in schizophrenic patients.
    Bagdy G; Perényi A; Arató M; Rotstein E
    Psychiatry Res; 1984 Jun; 12(2):177-8. PubMed ID: 6147870
    [No Abstract]   [Full Text] [Related]  

  • 14. Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment.
    Lichtshtein D; Dobkin J; Ebstein RP; Biederman J; Rimon R; Belmaker RH
    Br J Psychiatry; 1978 Feb; 132():145-8. PubMed ID: 623945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients.
    Licinio J; Seibyl JP; Altemus M; Charney DS; Krystal JH
    Am J Psychiatry; 1993 Sep; 150(9):1408-10. PubMed ID: 8102512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptics reduce spinal fluid cyclic AMP in schizophrenic patient.
    Biederman J; Rimon R; Ebstein R; Zohar J; Belmaker R
    Neuropsychobiology; 1976; 2(5-6):324-7. PubMed ID: 197445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid inositol monophosphatase: elevated activity in depression and neuroleptic-treated schizophrenia.
    Atack JR; Levine J; Belmaker RH
    Biol Psychiatry; 1998 Sep; 44(6):433-7. PubMed ID: 9777174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF dopamine beta-hydroxylase in schizophrenia.
    Sternberg DE; van Kammen DP; Lerner P; Ballenger JC; Marder SR; Post RM; Bunney WE
    Arch Gen Psychiatry; 1983 Jul; 40(7):743-7. PubMed ID: 6134515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin, dopamine and schizophrenia.
    Garver DL; Beinfeld MC; Yao JK
    Psychopharmacol Bull; 1990; 26(3):377-80. PubMed ID: 2274639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of cerebrospinal fluid angiotensin-converting enzyme in neuroleptic-treated schizophrenia.
    Wahlbeck K; Ahokas A; Nikkilä H; Miettinen K; Rimón R
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 May; 21(4):591-9. PubMed ID: 9194142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.